"The U.S. Food and Drug Administration today approved Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary di"...
Read this Medication Guide before you start taking DALIRESP® and each time you get a refill. There may be new information. This information does not take the place of talking with your healthcare provider about your medical condition or treatment.
What is the most important information I should know about DALIRESP?
DALIRESP can cause serious side effects. Tell your healthcare provider right away if you have any of the symptoms listed below while taking DALIRESP.
- DALIRESP may cause mental
health problems including suicidal thoughts and behavior. Some people taking DALIRESP may develop mood or behavior
- thoughts of suicide or dying
- attempt to commit suicide
- trouble sleeping (insomnia)
- new or worse anxiety
- new or worse depression
- acting on dangerous impulses
- other unusual changes in your behavior or mood
- Weight loss. DALIRESP can cause weight loss. You should check your weight on a regular basis. You will also need to see your healthcare provider regularly to have your weight checked. If you notice that you are losing weight, call your healthcare provider. Your healthcare provider may ask you to stop taking DALIRESP if you lose too much weight.
DALIRESP may affect the way other medicines work, and other medicines may affect how DALIRESP works. Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.
What is DALIRESP?
DALIRESP is a prescription medicine used in adults with severe Chronic Obstructive Pulmonary Disease (COPD) to decrease the number of flare-ups or the worsening of COPD symptoms (exacerbations).
DALIRESP is not a bronchodilator and should not be used for treating sudden breathing problems. Your healthcare provider may give you other medicine to use for sudden breathing problems. It is not known if DALIRESP is safe and effective in children.
Who should not take DALIRESP?
Do not take DALIRESP if you:
- have certain liver problems. Talk with your healthcare provider before you take DALIRESP if you have liver problems.
What should I tell my healthcare provider before taking DALIRESP?
Before you take DALIRESP, tell your healthcare provider if you:
- have or have had a history of mental health problems including depression and suicidal behavior.
- have liver problems
- have any other medical conditions
- are pregnant or plan to become pregnant. It is not known if DALIRESP will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant.
- are breastfeeding or plan to breastfeed. It is not known if DALIRESP passes into your breast milk. You and your healthcare provider should decide if you will take DALIRESP or breastfeed. You should not do both.
How should I take DALIRESP?
- Take DALIRESP exactly as your healthcare provider tells you to take it.
- DALIRESP can be taken with or without food.
- If you take more than your prescribed dose of DALIRESP, call your healthcare provider or go to the nearest hospital emergency room right away.
What are the possible side effects of DALIRESP?
DALIRESP can cause serious side effects, including:
See “What is the most important information I should know about DALIRESP?”
The most common side effects of DALIRESP include:
- weight loss
- back pain
- flu like symptoms
- problems sleeping (insomnia)
- decreased appetite
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of DALIRESP.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How do I store DALIRESP Tablets?
- Store DALIRESP at 68°F to 77°F (20°C to 25°C); excursions permitted to 15° -30°C (59° -86°F). [See USP Controlled Room Temperature].
Keep DALIRESP Tablets and all medicines out of the reach of children.
General information about DALIRESP
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use DALIRESP for a condition for which it was not prescribed. Do not give DALIRESP to other people, even if they have the same symptoms that you have. It may harm them.
This Medication Guide summarizes the most important information about DALIRESP. For more information about DALIRESP, talk with your healthcare provider. You can ask your healthcare provider or pharmacist for information about DALIRESP that is written for health professionals.
For more information about DALIRESP call 1-800-236-9933.
What are the ingredients in DALIRESP?
Active ingredient: roflumilast
Inactive ingredients: lactose monohydrate, corn starch, povidone and magnesium stearate.
This Medication Guide has been approved by the U.S. Food and Drug Administration.
Last reviewed on RxList: 12/7/2015
This monograph has been modified to include the generic and brand name in many instances.
Additional Daliresp Information
Daliresp - User Reviews
Daliresp User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.